Fiji vs Latvia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Fiji
28 patients
in 2021
Latvia
35 patients
in 2017
Fiji rank
95th
Latvia rank
93rd
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Fiji
- Latvia
How they compare
Latvia currently reports 35 patients against 28 patients in Fiji, a difference of 7 patients.
That makes Latvia's figure about 1.2 times Fiji's.
Across all 12 years both countries report, Latvia has been ahead every year.
Fiji ranks 95th and Latvia ranks 93rd of 183 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.5 patients | 32.5 patients | 32 patients | Latvia |
| 2010s | 6.12 patients | 48 patients | 41.88 patients | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Fiji or Latvia?
- Latvia, at 35 patients against 28 patients in Fiji as of 2017.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Fiji and Latvia?
- 7 patients, with Latvia ahead.
- How many years of comparable data are there for Fiji and Latvia?
- 12 years are reported by both, from 2005 to 2017.
- How do Fiji and Latvia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Fiji ranks 95th and Latvia ranks 93rd of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.